Art

J-GLOBAL ID：201702255347026937   Reference number：17A0465069

Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation

同種造血幹細胞移植後の持続静注から経口投与への切替え時のタクロリムス血中濃度に影響する変動因子の解析

Author (13)： SUETSUGU Kimitaka (Kyushu Univ. Hospital, Fukuoka, JPN) ,  SUETSUGU Kimitaka (Kyushu Univ., Fukuoka, JPN) ,  IKESUE Hiroaki (Kyushu Univ. Hospital, Fukuoka, JPN) ,  MIYAMOTO Toshihiro (Kyushu Univ. Graduate School of Medical Sci., Fukuoka, JPN) ,  SHIRATSUCHI Motoaki (Kyushu Univ. Graduate School of Medical Sci., Fukuoka, JPN) ,  YAMAMOTO-TAGUCHI Nanae (Kyushu Univ. Hospital, Fukuoka, JPN) ,  TSUCHIYA Yuichi (Kyushu Univ. Hospital, Fukuoka, JPN) ,  MATSUKAWA Kumi (Kyushu Univ. Hospital, Fukuoka, JPN) ,  UCHIDA Mayako (Kyushu Univ. Hospital, Fukuoka, JPN) ,  WATANABE Hiroyuki (Kyushu Univ. Hospital, Fukuoka, JPN) ,  AKASHI Koichi (Kyushu Univ. Graduate School of Medical Sci., Fukuoka, JPN) ,  MASUDA Satohiro (Kyushu Univ. Hospital, Fukuoka, JPN) ,  MASUDA Satohiro (Kyushu Univ., Fukuoka, JPN)
Material： International Journal of Hematology  (Int J Hematol)
Volume： 105  Issue： 3  Page： 361-368  Publication year： Mar. 2017 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： allogenic hematopoietic stem cell transplantation

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0465069&from=J-GLOBAL&jstjournalNo=F0888A") }}

JST classification (3)： Treatment for hematologic diseases in general  (GK05010E) ,  Clinical application of immunotherapeutic agents and blood preparations  (GW22020O) ,  Clinical biopharmacy  (GY01022L)

Substance index (1)： Tacrolimus

Reference (30)：

• Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 1998;92:2303-14.
• Przepiorka D, Khouri I, Ippoliti C, Ueno NT, Mehra R, Körbling M, et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. Bone Marrow Transpl. 1999;24:763-78.
• Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96:2062-8.
• Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, Kodera Y, et al. Japanese FK506 BMT(Bone Marrow Transplantation) Study Group. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transpl. 2001;28:181-5.
• Yanada M, Emi N, Naoe T, Sakamaki H, Takahashi S, Hirabayashi N, et al. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan. Bone Marrow Transpl. 2004;34:331-7.

Terms in the title (8)： 同種造血幹細胞移植 ,  持続静注 ,  経口投与 ,  切替え ,  タクロリムス ,  血中濃度 ,  因子 ,  解析